Calendrier des promotions Aadi Bioscience, Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise Aadi Bioscience, Inc.
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus bound to albumin. The company is also involved in evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.| IPO date | 2017-08-08 |
|---|---|
| ISIN | US00032Q1040 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://aadibio.com |
| Цена ао | 2.02 |
| Changement de prix par jour: | +1.49% (2.02) |
|---|---|
| Changement de prix par semaine: | +1.49% (2.02) |
| Changement de prix par mois: | +3.54% (1.98) |
| Changement de prix sur 3 mois: | -31.55% (2.995) |
| Changement de prix sur six mois: | -4.21% (2.14) |
| Changement de prix par an: | +7.89% (1.9) |
| Evolution du prix sur 3 ans: | -87.53% (16.44) |
| Evolution du prix sur 5 ans: | +355.96% (0.4496) |
| Evolution des prix depuis le début de l'année: | -13.14% (2.36) |
|
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
|||||||||||||||||||||||||||||||||||||
| Établissements | Volume | Partager, % |
|---|---|---|
| Avoro Capital Advisors LLC | 2849402 | 11.6 |
| Acuta Capital Partners LLC | 1849402 | 7.53 |
| Alerce Investment Management, L.P. | 1630830 | 6.64 |
| Blackrock Inc. | 1081631 | 4.41 |
| Vanguard Group Inc | 859697 | 3.5 |
| Decheng Capital LLC | 526329 | 2.14 |
| Decheng Capital Management III (Cayman), LLC | 526329 | 2.14 |
| Morgan Stanley | 510671 | 2.08 |
| Vivo Capital, LLC | 509572 | 2.08 |
| Citadel Advisors Llc | 407722 | 1.66 |
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
|---|---|---|---|
| Dr. Neil P. Desai Ph.D. | Founder & Executive Chairman | 710.35k | 1965 (60 années) |
| Dr. Loretta M. Itri F.A.C.P., M.D. | Chief Medical Officer | 617.45k | 1950 (75 années) |
| Mr. David J. Lennon Ph.D. | President, CEO & Director | 277.75k | 1971 (54 année) |
| Mr. Scott M. Giacobello CPA | CFO, Treasurer, Investor Relations & Corporate Communications | 643.23k | 1970 (55 années) |
| Mr. Stephen M. Rodin J.D. | Senior VP of Legal & General Counsel | N/A | 1976 (49 années) |
| Mr. Raymond G. Steitz | Senior VP of Human Resources & Chief Human Resources Officer | N/A | 1959 (66 années) |
| Mr. Bryan Ball | Chief Technical Operations Officer | N/A | 1970 (55 années) |
Adresse: United States, Pacific Palisades. CA, 17383 Sunset Boulevard - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://aadibio.com
Site web: https://aadibio.com
